AnaSpec Introduces Anti- β-Amyloid

San Jose, CA, May 27, 2011 --(PR.com)-- AnaSpec, Eurogentec Group is pleased to announce the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42). These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA. They also do not cross-react with β-amyloid (1-37) and β-amyloid (1-38). Species reactivity includes human, mouse and rat. The immunogen used in raising anti-β-amyloid (1-40) corresponds to amino acid 35-40 (MVGGVV), and for anti-β-amyloid (1-42), aa 35-42 (MVGGVVIA).

For more information please visit https://www.anaspec.com/products/promotions.asp?col=1&row=1.

AnaSpec, Eurogentec Group
AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com

###